Cornerstone Advisors (Washington)’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-33	Closed	-$2K	–	1218
2017 Q4	$2K	Sell	33 -15	-31%	-$821	﹤0.01%	836
2017 Q3	$3K	Hold	48	–	–	﹤0.01%	781
2017 Q2	$3K	Sell	48 -126	-72%	-$7.17K	﹤0.01%	777
2017 Q1	$9K	Buy	+174	New	+$8.57K	﹤0.01%	600

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Cornerstone Advisors (Washington)'s BIVV Position: Q1 2018 in Review

Cornerstone Advisors (Washington) sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 33 shares — an estimated $2K sold.

Cornerstone Advisors (Washington) first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $9K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Cornerstone Advisors (Washington) reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 33 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2K.
Cornerstone Advisors (Washington) first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Cornerstone Advisors (Washington)'s Bioverativ Inc. Common Stock position peaked at $9K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q1 2018, filed 19 Apr 2018.